T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 14,169,199 shares of IONS stock, worth $441 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
14,169,199
Previous 14,168,116
0.01%
Holding current value
$441 Million
Previous $568 Million
12.72%
% of portfolio
0.31%
Previous 0.34%
Shares
10 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$513 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$357 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$322 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$245 Million5.48% of portfolio
-
State Street Corp Boston, MA5.43MShares$169 Million0.01% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.42B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...